Go Pro

Polar Asset Management Partners Inc. Takes Position in CME Group Inc. $CME

CME Group logo with Finance background
Image from MarketBeat Media, LLC.

Polar Asset Management Partners Inc. bought a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 78,317 shares of the financial services provider's stock, valued at approximately $17,295,000.

Other hedge funds have also added to or reduced their stakes in the company. Jupiter Topco LLC acquired a new position in CME Group in the 2nd quarter valued at $395,519,000. EFG International AG bought a new position in CME Group during the 2nd quarter worth $33,768,000. Ancora Advisors LLC acquired a new stake in shares of CME Group during the second quarter worth $53,000. Primecap Management Co. CA acquired a new stake in shares of CME Group during the second quarter worth $420,602,000. Finally, PDT Partners LLC bought a new stake in shares of CME Group in the second quarter valued at about $13,250,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Down 0.7%

Shares of CME Group stock opened at $277.32 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The company has a market capitalization of $99.72 billion, a price-to-earnings ratio of 23.52, a PEG ratio of 3.32 and a beta of 0.23. The firm's 50-day moving average price is $251.75 and its two-hundred day moving average price is $279.35.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm's quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.96 EPS. On average, analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group's dividend payout ratio is presently 44.11%.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 325 shares of the business's stock in a transaction on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company's stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

CME has been the topic of several research reports. UBS Group decreased their price target on shares of CME Group from $310.00 to $260.00 and set a "buy" rating on the stock in a research note on Monday, July 6th. Keefe, Bruyette & Woods upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. Barclays dropped their price objective on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating for the company in a research note on Thursday, July 9th. Erste Group Bank downgraded shares of CME Group from a "buy" rating to a "hold" rating in a report on Friday, June 5th. Finally, Morgan Stanley increased their target price on shares of CME Group from $324.00 to $330.00 and gave the stock an "overweight" rating in a research report on Thursday, July 23rd. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $288.56.

View Our Latest Analysis on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines